MedPath

A human study to evaluate tolerance and safety of D-Allulose

Not Applicable
Completed
Conditions
Endocrine, nutritional and metabolic diseases
Registration Number
KCT0003989
Lead Sponsor
Samyang
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1) Subject who voluntarily agrees to participate and signs in informed consent form
2) Healthy people over 20 years old.

Exclusion Criteria

1) Subject with diseases and past medical history
2) Administration of drugs, dietary supplement, oriental medicine within 4 weeks before the
first visit
3) Subjects with hypersensitivity to test materials
4) Participation in other human study within 4 weeks before the first visit
5) Pregnant or lactating women

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hematological test(WBC, RBC, Hb et al.);Blood chemical test(ALP, BUN, creatinine et al.);Urine test(pH, protein,glucose et al.)
Secondary Outcome Measures
NameTimeMethod
Adverse events;Vital signs
© Copyright 2025. All Rights Reserved by MedPath